Abstract
Background Cardiac resynchronization therapy (CRT) is an effective treatment for patients with heart failure; however, 30% of patients do not respond to the treatment. We sought to derive patient-specific left-ventricle (LV) maps of lead placement scores (LPS) that highlight target pacing lead sites for achieving a higher probability of CRT response.
Methods Eighty-two subjects recruited for the ImagingCRT trial were retrospectively analyzed. All 82 subjects had two contrast-enhanced full-cardiac cycle 4DCT scans: a baseline and a 6-month follow-up scan. CRT response was defined as a reduction in CT-derived end-systolic volume ≥15%. Eight LV features derived from the baseline scans were used to train a support vector machine (SVM) via a bagging approach. An LPS map over the LV was created for each subject as a linear combination of the SVM feature weights and the subject’s own feature vector. Performance for distinguishing responders was performed on the original 82 subjects.
Results Fifty-two (63%) subjects were responders. Subjects with an LPS≤Q1 (lower-quartile) had a posttest probability of responding of 14% (3/21), while subjects with an LPS≥ Q3 (upper-quartile) had a posttest probability of responding of 90% (19/21). Subjects with Q1<LPS<Q3 had a posttest probability of responding that was essentially unchanged from the pretest probability (75% vs 63%, p=0.2). An LPS threshold that maximized the geometric mean of true-negative and true-positive rates identified 26/30 of the non-responders. The AUC of the ROC curve for identifying responders with an LPS threshold was 87%.
Conclusions An LPS map was defined using 4DCT-derived features of LV mechanics. The LPS correlated with CRT response, reclassifying 25% of the subjects into low-probability of response, 25% into high-probability of response, and 50% unchanged. These encouraging results highlight the potential utility of 4DCT in guiding patient selection for CRT. The present findings need verification in larger independent data sets and prospective trials.
Clinical Perspective Cardiac resynchronization therapy (CRT) is a proven treatment for patients with heart failure and dyssynchrony; however, approximately 30% of patients do not respond to the treatment. Additionally, the relatively high non-responder rate poses difficulties for the optimal utilization of medical resources; thus, more accurate patient stratification for CRT remains an unmet need. Despite significant efforts focused on using imaging to guide CRT, the results thus far have been ambiguous. Poor reproducibility of echocardiography coupled with the complexity of cardiac magnetic resonance have likely contributed to the poor overall adoption of these methods for pre-CRT assessment. In this work, we describe a metric called the lead placement score (LPS) that combines multiple 4DCT-derived features of left-ventricular (LV) mechanics into a single number for each possible pacing lead location on the LV; the features included in the LPS map have previously been shown to correlate with CRT response. Using a machine learning classifier, a model was constructed with these features and then used to derive the LPS map for each individual subject. The LPS was found to correlate with the probability of a subject responding to CRT. 4DCT is widely available and provides high-resolution images of the full cardiac cycle. Additionally, recent technological advancements have also dramatically reduced the radiation dose from 4DCT scans. The advantages of 4DCT coupled with the promising results reported in this study, highlight the potential utility of 4DCT in the planning of CRT.
Competing Interest Statement
Dr. McVeigh holds founder shares in Clearpoint Neuro Inc. and receives research funding from GE Healthcare, Abbott Medical, and Pacesetter Inc.
Funding Statement
This study was funded by the NIH (R01HL144678, F31HL151183), AHA (20PRE35210261), Aarhus University, Danish Heart Foundation(11-04-R84-A3234-22641), Danish Council for Independent Research (11-107461), Central Denmark Region (1-45-72-4-09), Eva and Henry Frænkels Foundation, and Manufacturer Karl G. Andersens Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of Central Denmark Regional Committee on Health Research Ethics gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Non-standard Abbreviations and Acronyms
- CRT
- cardiac resynchronization therapy
- NYHA
- New York Heart Association
- LVEF
- left ventricular ejection fraction
- LV
- left ventricle
- CMR
- cardiac magnetic resonance
- RV
- right ventricle
- MACE
- major adverse cardiac events
- LPS
- lead placement score
- LBBB
- left bundle branch block
- LVOT
- left ventricular outflow tract
- EDV
- end diastolic volume
- ESV
- end systolic volume
- CURE
- circumferential uniformity ratio estimate
- SVD
- singular value decomposition
- CURE-SVD
- circumferential uniformity ratio estimate using singular value decomposition
- LVSI
- left ventricular sphericity index
- RSCT
- regional shortening
- PRSCT
- peak regional shortening
- TPRSCT
- time to peak regional shortening
- MSRSCT
- maximum stretch of regional shortening
- TOS
- time to onset of shortening
- SVM
- support vector machine
- IQR
- interquartile range
- ROC
- receiver operating characteristic
- AUC
- area under curve
- CI
- confidence interval